Roger Adsett
Directeur des opérations chez INSMED INCORPORATED
Fortune : 4 M $ au 30/04/2024
Postes actifs de Roger Adsett
Sociétés | Poste | Début | Fin |
---|---|---|---|
INSMED INCORPORATED | Directeur des opérations | 14/11/2019 | - |
Corporate Officer/Principal | 27/09/2016 | 14/11/2019 |
Historique de carrière de Roger Adsett
Anciens postes connus de Roger Adsett
Sociétés | Poste | Début | Fin |
---|---|---|---|
LANDOS BIOPHARMA, INC. | Directeur/Membre du Conseil | 08/03/2022 | 23/05/2024 |
Independent Dir/Board Member | 08/03/2022 | 23/05/2024 | |
SHIRE | Corporate Officer/Principal | 01/10/2005 | 01/09/2016 |
ASTRAZENECA PLC | Sales & Marketing | 01/11/1994 | 01/10/2005 |
Nexium, Inc. | Sales & Marketing | - | - |
AstraZeneca R & D Lund | Sales & Marketing | - | - |
Formation de Roger Adsett
Bucknell University | Undergraduate Degree |
The Wharton School of the University of Pennsylvania | Masters Business Admin |
Statistiques
Internationale
Etats-Unis | 6 |
Royaume-Uni | 2 |
Irlande | 2 |
Opérationnelle
Sales & Marketing | 3 |
Corporate Officer/Principal | 2 |
Chief Operating Officer | 1 |
Sectorielle
Health Technology | 5 |
Consumer Services | 3 |
Finance | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 3 |
---|---|
ASTRAZENECA PLC | Health Technology |
INSMED INCORPORATED | Health Technology |
LANDOS BIOPHARMA, INC. | Health Technology |
Entreprise privées | 3 |
---|---|
Shire Plc
Shire Plc Pharmaceuticals: MajorHealth Technology Shire Plc is a biopharmaceutical company, which engages in the research, development, licensing, manufacturing, marketing, distribution, and sale of medicines. Its products include adderall, advate, adynovate, agrylin, antithrombin 3, aralast, bebulin, buccolam, feiba, firazyr, and foznol. The company was founded in 1986 and is headquartered in Dublin, Ireland. | Health Technology |
Nexium, Inc. | Finance |
AstraZeneca R & D Lund |
- Bourse
- Insiders
- Roger Adsett
- Expérience